| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/01/2023 | 8.44% | Morgan Stanley | $9 → $9.25 | Maintains | Equal-Weight |
| 06/30/2023 | 28.96% | Scotiabank | → $11 | Reiterates | Sector Outperform → Sector Outperform |
| 06/26/2023 | 5.51% | Morgan Stanley | $8.5 → $9 | Reiterates | Equal-Weight → Equal-Weight |
| 06/16/2023 | 23.09% | Citigroup | → $10.5 | Reiterates | Buy → Buy |
| 03/22/2023 | 5.51% | Mizuho | → $9 | Initiates Coverage On | → Buy |
| 03/16/2023 | -0.35% | Keefe, Bruyette & Woods | $9 → $8.5 | Maintains | Market Perform |
| 03/14/2023 | — | Wolfe Research | Upgrades | Peer Perform → Outperform | |
| 12/12/2022 | -0.35% | Morgan Stanley | $12.75 → $8.5 | Maintains | Equal-Weight |
| 12/08/2022 | 11.37% | Goldman Sachs | $11 → $9.5 | Downgrades | Buy → Neutral |
| 11/30/2022 | — | Wolfe Research | Initiates Coverage On | → Peer Perform | |
| 11/14/2022 | 28.96% | RBC Capital | $12 → $11 | Maintains | Outperform |
| 10/18/2022 | 28.96% | Goldman Sachs | $14.75 → $11 | Maintains | Buy |
| 09/19/2022 | — | Citigroup | Upgrades | Neutral → Buy | |
| 08/25/2022 | 49.47% | Morgan Stanley | $11.75 → $12.75 | Maintains | Equal-Weight |
| 08/02/2022 | 87.57% | Raymond James | $17 → $16 | Upgrades | Outperform → Strong Buy |
| 07/15/2022 | 37.75% | Morgan Stanley | $13.5 → $11.75 | Maintains | Equal-Weight |
| 05/27/2022 | 58.26% | Morgan Stanley | $15.75 → $13.5 | Maintains | Equal-Weight |
| 05/12/2022 | 99.3% | TD Securities | $18 → $17 | Upgrades | Hold → Buy |
| 05/12/2022 | 99.3% | RBC Capital | $18 → $17 | Maintains | Outperform |
| 03/31/2022 | 111.02% | TD Securities | $17 → $18 | Downgrades | Buy → Hold |
| 03/28/2022 | 116.88% | Raymond James | → $18.5 | Initiates Coverage On | → Outperform |
| 12/06/2021 | 93.43% | Goldman Sachs | → $16.5 | Initiates Coverage On | → Buy |
| 11/01/2021 | 84.64% | Morgan Stanley | → $15.75 | Initiates Coverage On | → Equal-Weight |
| 10/22/2021 | 87.57% | RBC Capital | $15.5 → $16 | Maintains | Outperform |
| 10/13/2021 | 81.71% | RBC Capital | $14 → $15.5 | Maintains | Outperform |
What is the target price for Tricon Residential (TCN)?
The latest price target for Tricon Residential (NYSE: TCN) was reported by Morgan Stanley on September 1, 2023. The analyst firm set a price target for $9.25 expecting TCN to rise to within 12 months (a possible 8.44% upside). 13 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Tricon Residential (TCN)?
The latest analyst rating for Tricon Residential (NYSE: TCN) was provided by Morgan Stanley, and Tricon Residential maintained their equal-weight rating.
When is the next analyst rating going to be posted or updated for Tricon Residential (TCN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Tricon Residential, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Tricon Residential was filed on September 1, 2023 so you should expect the next rating to be made available sometime around September 1, 2024.
Is the Analyst Rating Tricon Residential (TCN) correct?
While ratings are subjective and will change, the latest Tricon Residential (TCN) rating was a maintained with a price target of $9.00 to $9.25. The current price Tricon Residential (TCN) is trading at is $8.53, which is out of the analyst's predicted range.